Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Autologous SVF Injection with Endoscopic Urethrotomy in Bulbar Urethral Stenosis
2024-513306-65-00Phase 2Suspended
- Sponsor
- Assistance Publique–Hôpitaux de Marseille
- Start
- Jul 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of autologous adipose-derived stromal vascular fraction cells in Urethral stenosis (2 arms), sponsored by Assistance Publique–Hôpitaux de Marseille. Primary endpoint: Safety of urethrotomy with or without adjuvant SVF injection. Started Jul 2024; status: suspended.
02
Drugs
autologous adipose-derived stromal vascular fraction cells
03
Conditions
Urethral stenosis
Beyond the preview
Go deeper on 2024-513306-65-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513306-65-00.